|Bid||37.88 x 1000|
|Ask||37.94 x 800|
|Day's range||37.24 - 38.59|
|52-week range||28.03 - 48.50|
|Beta (5Y monthly)||1.12|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
LEWISVILLE, Texas, August 02, 2021--First implant completed in Orthofix study evaluating the M6-C artificial cervical disc for treating degenerative disc disease at two vertebral levels.
LEWISVILLE, Texas, July 28, 2021--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that it plans to release financial results for the second quarter 2021 before market open on Friday, August 6, 2021. Jon Serbousek, President and Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Company’s results at 8:30 a.m. ET the same day.
LEWISVILLE, Texas, July 28, 2021--Orthofix launches the fiberFUSE™ Strip, a preformed bone-graft optimized for posterior cervical, posterior lumbar and degenerative spinal procedures.